Dopamine agonist probably leads to lower incidence of moderate or severe OHSS compared with placebo/no intervention (moderate certainty).
It is very uncertain whether dopamine agonist changes incidence of moderate or severe OHSS compared with other active intervention (very low certainty).
Dopamine agonist showed no clear difference in live birth rate compared with other active intervention (low certainty).
Dopamine agonist showed no clear difference in clinical pregnancy rate compared with other active intervention (moderate certainty).
Dopamine agonist showed no clear difference in multiple pregnancy rate compared with other active intervention (low certainty).
Dopamine agonist showed no clear difference in miscarriage rate compared with other active intervention (low certainty).
Dopamine agonist showed no clear difference in live birth rate compared with placebo/no intervention (low certainty).
Dopamine agonist showed no clear difference in clinical pregnancy rate compared with placebo/no intervention (low certainty).
It is very uncertain whether dopamine agonist changes multiple pregnancy rate compared with placebo/no intervention (very low certainty).
Dopamine agonist showed no clear difference in miscarriage rate compared with placebo/no intervention (low certainty).
It is very uncertain whether dopamine agonist changes any other adverse events compared with placebo/no intervention (very low certainty).
Any dopamine agonist showed no clear difference in dropouts compared with placebo (moderate certainty).
Any dopamine agonist showed no clear difference in adverse events as N of participants with at least one adverse event compared with placebo (moderate certainty).
Any dopamine agonist showed no clear difference in abstinence (objective) Participants abstinent at the end of… compared with placebo (low certainty).
Any dopamine agonist showed no clear difference in abstinence at compared with placebo (low certainty).
It is very uncertain whether dopamine agonist plus co‐intervention changes multiple pregnancy rate compared with co‐intervention (very low certainty).
Dopamine agonist plus co‐intervention showed no clear difference in miscarriage rate compared with co‐intervention (low certainty).
It is very uncertain whether dopamine agonist plus co‐intervention changes any other adverse events compared with co‐intervention (very low certainty).